Back to search

Aurobac Therapeutics Uk Limited

14939347

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

30 OLD BAILEY, LONDON, EC4M 7AU
Incorporated 15/06/2023

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Florence Marie-Claude Suzette Sejourne

director · Since 15/06/2023

CEO

FRENCH · FRANCE · Age 54

CompanyRankvs 1405+ SIC 72110 peers
45

Financial strength72th percentile among SIC peers · 18/25
Employees47th percentile among SIC peers · 7/15
LiquidityCurrent ratio 1.23× · 12/20
Longevity3 years trading (max 15) · 3/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength18/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity3/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

as this is the currency of the primary economic environment in which the company operates and is rounded to the nearest pound. The following principal accounting policies have been applied: 2.2 Going concern The financial statements have been prepared on a going concern basis. The Company’s ability to continue as a going concern is dependent on the continued financial support from its parent

Key FinancialsYear ending 31/12/2024

Net Worth

£31k

Balance sheet strength

Cash

£69k

Cash in the bank

Net Current Assets

£31k

Working capital

Current Assets

£165k

Current Liabilities

£134k

Debtors

£96k

1avg. employees

Tax at Year End

Corp tax£7k

Balance Sheet

Assets less current liabilities£31k
Prepared with Caseware UK (AP4) 2023.0.135

EstimatesDerived

YearCurrent RatioImplied Profit
20241.23+£19k
20231.04

Derived from filed accounts. Not audited figures.